Great 4th quarter sales results.All sales metrics up.Financial year 2018 looks to be shaping up as a great year for IBN.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025